Back to results
US 10,537,567 B2Granted
Kinase inhibitors for treatment of disease
AssigneeBioAxone BioSciences, Inc.
InventorsJoerg Ruschel, Matthew D. Abbinanti, Kenneth M. Rosen, Lisa McKerracher
Life of this patent
Estimating the term…
Abstract
Disclosed are therapeutic compositions including BA-1076 and/or BA-2057, methods of their use in the treatment of ophthalmological disorders. The therapeutic compositions may further include an IOP-lowering prostaglandin. The methods may further include administration of an IOP-lowering prostaglandin.
Claims19
A therapeutic composition comprising a therapeutically effective amount of a compound of formula:
- or a pharmaceutically acceptable salt thereof,
- wherein BA-1076 or a pharmaceutically acceptable salt thereof is present in at least 10% enantiomeric excess.
A therapeutic composition comprising a therapeutically effective amount of a compound of formula:
- or a pharmaceutically acceptable salt thereof,
- wherein BA-2057 or a pharmaceutically acceptable salt thereof is present in at least 10% enantiomeric excess.
Dependencies are inferred from the claim text.